The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......
The Central Drugs Standard Control Organisation has found Alkem Labs’ anti-diabetic drug Glimekem to be of substandard quality. This is the third time in the past one year that the......
The Israel-based multinational Taro Pharmaceutical Industries has struck its first outsourcing deal with Indian major Alkem Laboratories for formulations development and supply contract for its US......
Six pharma majors were sent seven alerts last financial year At least six major pharmaceutical companies, including Cipla, Ipca Labs, Alkem Labs, Morepen Labs, Abbott and Sanofi were found......
Indian companies have raised $1 billion so far this year - almost four times what they raised last year. Two high-profile market debuts in India this month could raise up to $500 million, the......